glp 1 new indications How Employers Can Optimize Benefits in the Era of GLP-1s The expanding landscape of GLP-1
Description
Then, we would add a side of crinkle fries for good measure
Psichas, A., Larraufie, P
Even when these drugs contain the same active ingredients, they are FDA-approved for different indications
When evaluating individual components of the composite outcome, both oral corticosteroid use (adjusted IRR: 0.54, 95% CI: 0.410.70) and IBD-related hospitalization (adjusted IRR: 0.73, 95% CI: 0.580.91) were significantly lower amongst GLP-1 RA/DPP-4 inhibitor users
, & Lee, S
